Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

PURPOSE: Sotatercept may represent a novel approach to the treatment of chemotherapy-induced anemia (CIA). We report the results from two phase 2 randomized studies examining the use of sotatercept for the treatment of CIA in patients with metastatic cancer. METHODS: In study A011-08, patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Raftopoulos, Haralambos, Laadem, Abderrahmane, Hesketh, Paul J., Goldschmidt, Jerome, Gabrail, Nashat, Osborne, Cynthia, Ali, Muhammad, Sherman, Matthew L., Wang, Ding, Glaspy, John A., Puccio-Pick, Marie, Zou, Jun, Crawford, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766217/
https://www.ncbi.nlm.nih.gov/pubmed/26370220
http://dx.doi.org/10.1007/s00520-015-2929-9

Ejemplares similares

Ejemplares similares